# First Study in Humans With GSK206136

> **NCT01059578** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 33 (actual)

## Conditions studied

- Depressive Disorder and Anxiety Disorders

## Interventions

- **DRUG:** GSK206136
- **DRUG:** PLACEBO
- **RADIATION:** PET

## Key facts

- **NCT ID:** NCT01059578
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05-23
- **Primary completion:** 2006-12-18
- **Final completion:** 2006-12-18
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2017-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01059578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01059578, "First Study in Humans With GSK206136". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01059578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*